12 Health Care Stocks Moving In Tuesday’s After-Market Session
Gainers Arcutis Biotherapeutics (NASDAQ:ARQT) stock moved upwards by 16.4% to $9.46 during Tuesday’s after-market session. The company’s market…
12 Health Care Stocks Moving In Thursday’s Intraday Session
Gainers Emergent BioSolutions (NYSE:EBS) stock moved upwards by 98.4% to $3.83 during Thursday’s regular session. The company’s market…
Around $2M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying
The Dow Jones index closed higher by around 250 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
12 Health Care Stocks Moving In Monday’s After-Market Session
Gainers Jin Medical International (NASDAQ:ZJYL) stock moved upwards by 72.5% to $175.76 during Monday’s after-market session. The market…
BioAtla Hosting Virtual R&D Day To Highlight BA3071 CAB-CTLA-4 Phase 1 Data In Multiple Solid Tumor Types
Multiple confirmed responses and durable disease control observed Emerging differentiated safety profile enables further exploration at higher dosesOngoing Phase 2 clinical study of monotherapy and in combination
BioAtla Presented Phase 2 Clinical Trial Data At The IASLC 2023 North America Conference On Lung Cancer And Virtual KOL Event
Results from the Phase 2 BA3011 clinical non-small cell lung cancer (NSCLC) study demonstrated promising clinical benefits in heavily pre-treated non-squamous histology patients across key endpoints BA3011 is a
12 Health Care Stocks Moving In Monday’s Intraday Session
Gainers EyePoint Pharmaceuticals (NASDAQ:EYPT) stock rose 172.8% to $18.03 during Monday’s regular session. The company’s market cap stands…
Earnings Scheduled For November 7, 2023
Companies Reporting Before The Bell
• CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings for its third quarter.
Analyst Ratings for BioAtla
Within the last quarter, BioAtla (NASDAQ:BCAB) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat Bearish…
Stocks That Hit 52-Week Lows On Friday
Friday's session saw 169 companies set new 52-week lows.